Cipher began collecting rent at Black Pearl two months early and completed an $810 million secured notes offering to fund Stingray, while its Texas development pipeline expanded near San Antonio.
News
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
Exciting developments are taking place for the stocks in this article. They’ve all surged ahead of the broader market over the last month as catalysts such as new products and positive media coverage have propelled their returns.
Micron stock rose Tuesday as new figures show growing market share but there's a threat on the horizon.
Upbound is leaning on Brigit's rapid expansion and Acima's margin gains, but can those strengths overcome weak demand and drive a lasting rebound?
(Bloomberg) -- Refineries outside of conflict zones are running at full tilt across the world and there are few shock absorbers left in the system to protect against higher fuel prices, the world’s biggest oil company Saudi Aramco said.Most Read from BloombergBeer Dynasty Families Sell €731 Million Stake in AB InBevTaco Bell Met With Michigan on Parasite Weeks Before RecallApple’s New CEO Taps Retired Hardware Executive for Management TeamMamdani Dismisses Business Leaders Advising NYC’s Mayor’s
Merck (NYSE:MRK) shares moved higher in pre-market trading after the pharmaceutical company reported second-quarter 2026 results that exceeded Wall Street expectations and raised its full-year revenue guidance. Although Merck reduced its adjusted earnings outlook to reflect acquisition-related charges, investors welcomed the stronger-than-expected quarterly performance and improved sales forecast.
Despite another strong earnings report, analysts warned that upcoming cystic fibrosis data from Sionna Therapeutics "looms large" over Vertex.
News of the day for Aug. 4, 2026
Nvidia stock has lagged behind the PHLX Semiconductor Index, which is up 61% this year so far through Monday’s close.
Aerospace and defense company TransDigm (NYSE:TDG) reported Q2 CY2026 results topping the market’s revenue expectations, with sales up 22.5% year on year to $2.74 billion. The company’s full-year revenue guidance of $10.51 billion at the midpoint came in 1.3% above analysts’ estimates. Its non-GAAP profit of $10.87 per share was 5.2% above analysts’ consensus estimates.
(Bloomberg) -- Polymarket is seeking to raise capital at a valuation of more than $20 billion, months after it closed an earlier round with new investment from hedge fund D.E. Shaw & Co.Most Read from BloombergBeer Dynasty Families Sell €731 Million Stake in AB InBevTaco Bell Met With Michigan on Parasite Weeks Before RecallApple’s New CEO Taps Retired Hardware Executive for Management TeamMamdani Dismisses Business Leaders Advising NYC’s Mayor’s FundChina’s AI Blitz Creates ‘Death Zone’ for Riv
Nvidia's revenue has nearly tripled in two years while AMD's growth has stalled, widening a gap that raises questions about competitive positioning.
Why Coupang’s upcoming earnings matter for investors Coupang (CPNG) is set to report Q2 2026 results after the close on August 4, with the market watching how a projected 6.2% revenue increase compares with last year’s 16.4% pace. See our latest analysis for Coupang. Coupang’s share price has been under pressure in 2026, with a year to date share price return down 29.74% and a 1 year total shareholder return down 45.08%. However, the 7 day share price return of 6.35% suggests some short term...
While Philip Morris International has underperformed the S&P Index over the past year, analysts remain moderately optimistic on its future growth prospects.
Pfizer (NYSE:PFE) reported positive Phase 3 results for LITFULO in nonsegmental vitiligo. The company plans to pursue global regulatory filings for LITFULO as an oral therapy for this autoimmune skin disease. For investors watching Pfizer, this update highlights an area of its late stage pipeline that sits outside its COVID and oncology businesses. Nonsegmental vitiligo is a chronic condition with limited systemic treatment options, so additional clinical data around efficacy and safety is...
Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn’t mean it will thrive tomorrow.
Caterpillar ended the second quarter with $6.7 billion of enterprise cash, higher than $5.4 billion for the same period last year.
Snap Inc. has just reported its second-quarter 2026 results, with revenue rising to US$1,598.99 million from US$1,344.93 million a year earlier and net loss narrowing to US$163.96 million from US$262.57 million, supported by gains in advertising and subscription revenue plus positive free cash flow. The quarter also marked continued user and monetization progress, as daily active users reached 493 million and average revenue per user climbed to US$3.25, while Snap pressed ahead with AI...
AstraZeneca (LSE:AZN) is reported to be in advanced merger talks with Bristol Myers Squibb. The potential deal could create a combined pharmaceutical company valued at about US$400b. The transaction, if completed, would rank among the largest in the sector and could significantly affect competitive positions in oncology. Regulators are expected to review any agreement closely due to overlapping product portfolios. AstraZeneca is a global pharmaceutical company with a significant focus on...
Pre-Market Stock Futures: Futures are trading higher after a solid start to August, with all major indices finishing higher on Monday. The President tapping the brakes on attacks on Iran and a return to the negotiating table, combined with massive technology earnings and tumbling oil prices, was just the ticket for traders and investors to ... Here Are Tuesday’s Top Wall Street Analyst Research Calls: Apple, CoreWeave, eBay, Exxon Mobil, Intuit, Nebius Group, Palantir Technologies, SK hynix, and
Which big tech giants can actually prove their AI spending is paying off? Microsoft and Amazon show some clear numbers; the rest will make you squint.
Michael Saylor said his “Never Sell Your Bitcoin” message referred to his personal holdings rather than Strategy’s corporate treasury. Strategy sold 1,638 BTC for approximately ...
The number you need to know on Palantir right after earnings.
SpaceX stock faces its first earnings test. Here's what investors need to watch
For much of the past decade, investors treated oil price spikes as temporary disruptions that eventually faded. That assumption is becoming harder to defend. The Iran war has fundamentally changed the balance between global supply and demand, and the world’s oil market is still struggling to recover. Before hostilities erupted, West Texas Intermediate (WTI) crude ... Diamondback Energy Reveals Brutal Truth: High Oil Prices Are Here to Stay
Micron Technology (NASDAQ:MU) has had one of the wildest rides in the market this year. The stock is still up roughly 190% in 2026, but it has also fallen more than 25% from the all-time high it set in late June, including an approximate 9% single-day drop on July 28 as chip stocks sold off […]
Analyst upgrades are piling up ahead of earnings
Third Point Management, a New York-based investment advisor, released its second-quarter 2026 investor letter. A copy is available to download here. Third Point’s flagship Offshore Fund returned 7.7% in Q2 2026, outperforming the hedge fund index but trailing broader equity benchmarks. Second Quarter returns benefited from strong performance in semiconductors, memory, semiconductor equipment, power infrastructure, […]
Pfizer faces $17 billion patent cliff as investors brace for earnings
Catapillar stock jumped on Tuesday as quarterly revenue topped $20 billion for the first time.